Cargando…

Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass

Type 2 diabetes mellitus (T2DM) is a prevalent disease worldwide and during its conventional treatment, vascular complications remain unavoidable. Roux-en-Y gastric bypass (GBP) is able to induce the remission of T2DM. However, studies of duodenal-jejunal bypass (DJB), a modified procedure of GBP, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, XUAN, HUANG, ZHEN, RAN, WENHUA, LIAO, GANG, ZHA, LANG, WANG, ZIWEI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113651/ https://www.ncbi.nlm.nih.gov/pubmed/25120614 http://dx.doi.org/10.3892/etm.2014.1832

Ejemplares similares

Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus
por: Chen, Ji-Hua, et al.
Publicado: (2022)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

DUODENAL-JEJUNAL BYPASS REDUCES LIPID ACCUMULATION IN THE BROWN ADIPOSE TISSUE OF HYPOTHALAMIC OBESE RATS
por: CEGLAREK, Vanessa Marieli, et al.
Publicado: (2020)

Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial
por: Ruban, Aruchuna, et al.
Publicado: (2022)

Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats
por: Cantelli, K.R., et al.
Publicado: (2017)

Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
por: Okikawa, Shohei, et al.
Publicado: (2023)

Duodenal-Jejunal Bypass Surgery Reverses Diabetic Phenotype and Reduces Obesity in db/db Mice
por: Liang, Yongjun, et al.
Publicado: (2017)

Effects and mechanism of duodenal-jejunal bypass and sleeve gastrectomy on GLUT2 and glucokinase in diabetic Goto–Kakizaki rats
por: Donglei, Zhou, et al.
Publicado: (2012)

The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
por: Ruban, Aruchuna, et al.
Publicado: (2018)

A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease
por: Ghoz, Hassan, et al.
Publicado: (2020)

The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
por: Gao, Yi, et al.
Publicado: (2021)

Feasibility of a new bariatric fully endoscopic duodenal-jejunal bypass: a pilot study in adult obese pigs
por: Gonzalez, Jean-Michel, et al.
Publicado: (2022)

Absence of Role of Dietary Protein Sensing in the Metabolic Benefits of Duodenal-Jejunal Bypass in the Mouse
por: Barataud, Aude, et al.
Publicado: (2017)

Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats
por: Han, Hai-Feng, et al.
Publicado: (2022)

Concurrent Placements of a Duodenal-Jejunal Bypass Liner and an Intragastric Balloon Among Severely Obese Patients: A Case Series
por: Sartoretto, Adrian, et al.
Publicado: (2019)

Single-Anastomosis Duodenal Jejunal Bypass Improve Glucose Metabolism by Regulating Gut Microbiota and Short-Chain Fatty Acids in Goto-Kakisaki Rats
por: Yu, Xiang, et al.
Publicado: (2020)

The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study
por: van Rijn, Selwyn, et al.
Publicado: (2017)

Conversion of Roux-en-Y gastric bypass to single anastomosis duodenal ileal bypass with sleeve gastrectomy with gastrogastric jejunal bridge
por: Dib, Victor Ramos Mussa, et al.
Publicado: (2022)

Duodenal-Jejunal Bypass Surgery Stimulates the Expressions of Hepatic Sirtuin1 and 3 and Hypothalamic Sirtuin1
por: Ha, Eunyoung, et al.
Publicado: (2018)

A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
por: Glaysher, Michael Alan, et al.
Publicado: (2017)

Duodenal and jejunal Dieulafoy’s lesions: optimal management
por: Yılmaz, Tonguç Utku, et al.
Publicado: (2017)

Effect of duodenal-jejunal bypass surgery on glycemic control in type 2 diabetes: a randomized controlled trial
por: Petry, Tarissa Z., et al.
Publicado: (2015)

miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal–jejunal bypass
por: Guo, W, et al.
Publicado: (2016)

Alteration of Ileal lncRNAs After Duodenal–Jejunal Bypass Is Associated With Regulation of Lipid and Amino Acid Metabolism
por: Liang, Yongjun, et al.
Publicado: (2022)

Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis
por: Karlas, Thomas, et al.
Publicado: (2022)

FIXING JEJUNAL MANEUVER TO PREVENT PETERSEN HERNIA IN GASTRIC BYPASS
por: MURAD-JUNIOR, Abdon José, et al.
Publicado: (2015)

Development of the duodenal, ileal, jejunal and caecal microbiota in chickens
por: Glendinning, Laura, et al.
Publicado: (2019)

Duodenal-jejunal bypass reduces serum ceramides via inhibiting intestinal bile acid-farnesoid X receptor pathway
por: Cheng, Zhi-Qiang, et al.
Publicado: (2022)

Restoration of myocardial glucose uptake with facilitated myocardial glucose transporter 4 translocation contributes to alleviation of diabetic cardiomyopathy in rats after duodenal‐jejunal bypass
por: Huang, Xin, et al.
Publicado: (2018)

Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service
por: Ryder, Robert E. J., et al.
Publicado: (2022)

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation
por: Betzel, B., et al.
Publicado: (2019)

Does Bypass of the Proximal Small Intestine Impact Food Intake, Preference, and Taste Function in Humans? An Experimental Medicine Study Using the Duodenal-Jejunal Bypass Liner
por: Aldhwayan, Madhawi M., et al.
Publicado: (2022)

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
por: Ryder, Robert E.J., et al.
Publicado: (2023)

Application of Jejunal Nutrient Tube in Congenital Duodenal Obstruction in Children
por: CAO, Junhua, et al.
Publicado: (2018)

Duodenal-jejunal bypass liner implantation provokes rapid weight loss and improved glycemic control, accompanied by elevated fasting ghrelin levels
por: Koehestanie, Parweez, et al.
Publicado: (2014)

ASSESSMENT OF THE GASTRO-JEJUNO-DUODENAL TRANSIT AFTER JEJUNAL POUCH INTERPOSITION
por: da SILVA, Alcino Lázaro, et al.
Publicado: (2015)

Improved FGF21 Sensitivity and Restored FGF21 Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats After Duodenal-Jejunal Bypass and Sleeve Gastrectomy
por: Liu, Qiaoran, et al.
Publicado: (2019)

Pseudo Double Bubble: Jejunal Duplication Mimicking Duodenal Atresia on Prenatal Ultrasound
por: Schwartzberg, David, et al.
Publicado: (2013)

Duodenitis‐Proximal Jejunitis in Horses After Experimental Administration of Clostridium difficile Toxins
por: Arroyo, L.G., et al.
Publicado: (2016)

Antioxidant Status in the Soleus Muscle of Sprague-Dawley Rats in Relation to Duodenal-Jejunal Omega Switch and Different Dietary Patterns
por: Skrzep-Poloczek, Bronisława, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c70jsdk3pjdad12rrencke1a0l